Rezny Wealth Management’s Pfizer PFE Stock Holding History

Rezny Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-422	Closed	-$12K	–	36
2015 Q4	$12K	Sell	422 -799	-65%	-$25.1K	0.01%	25
2015 Q3	$36K	Hold	1,221	–	–	0.04%	21
2015 Q2	$38K	Buy	+1,221	New	+$39.8K	0.03%	22

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Rezny Wealth Management's PFE Position: Q1 2016 in Review

Rezny Wealth Management sold out of Pfizer (PFE) in Q1 2016, closing a stake of 422 shares — an estimated $12K sold.

Rezny Wealth Management first reported a position in PFE in Q2 2015 and held it in 3 quarters. The position peaked at $38K in Q2 2015. 1,967 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

Rezny Wealth Management reported no remaining Pfizer position as of Q1 2016 after selling out during the quarter.
Rezny Wealth Management sold 422 Pfizer shares in Q1 2016, an estimated $12K.
Rezny Wealth Management first reported a position in Pfizer in Q2 2015 and held it in 3 quarters.
Rezny Wealth Management's Pfizer position peaked at $38K in Q2 2015.
1,967 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Rezny Wealth Management's 13F filing for Q1 2016, filed 10 May 2016.